Comparison of clinical outcomes of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations after tyrosine kinase inhibitors treatment: a meta-analysis
収録刊行物
-
- European Journal of Clinical Pharmacology
-
European Journal of Clinical Pharmacology 72 (1), 1-11, 2015-10-21
Springer Science and Business Media LLC